Type III IFNs was recently shown to produce anti-proliferative actions in a number of cancer cells [7,17], but the present study demonstrated that IFN-λ1 did not inhibit growth of mesothelioma cells due to the lack of IL-28Rα expression. The gene discussed is IFNLR1; the disease is cancer.